Systemic administration of replication-selective adenoviruses

被引：0
|
作者：
Kirn, D [1 ]
机构：
[1] Hammersmith Hosp, Imperial Canc Res Fund, Mol Oncol Unit, Viral & Gene Therapy Program, London, England
来源：
CANCER GENE THERAPY | 2001年 / 8卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O29
引用
收藏
页码：917 / 917
页数：1
相关论文
共 50 条
  • [21] Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
    Zeh, HJ
    Bartlett, DL
    [J]. CANCER GENE THERAPY, 2002, 9 (12) : 1001 - 1012
  • [22] Manufacture of a Replication-Selective and Enhanced-Lytic Adenovirus Vector
    Artlip, Moria
    Ishikawa, Sawako
    Jendrek, Scott
    Poon, Dexter T. K.
    [J]. MOLECULAR THERAPY, 2006, 13 : S55 - S55
  • [23] Development of recombinant of replication-selective adenovirus mutant and ricin A chain
    Lin, SY
    Jie, C
    Hu, HQ
    Tan, LY
    Kong, XT
    [J]. EUROMEDLAB 2003: PROCEEDINGS OF THE 15TH IFCC-FESCC EUROPEAN CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, : 865 - 866
  • [24] Comparison of replication-selective, oncolytic viruses for the treatment of human cancers
    Wildner, O
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (04) : 351 - 361
  • [25] Telomerase-specific replication-selective virotherapy for human cancer
    Kawashima, T
    Kagawa, S
    Kobayashi, N
    Shirakiya, Y
    Umeoka, T
    Teraishi, F
    Kyo, S
    Taki, M
    Tanaka, N
    Fujiwara, T
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (01) : 285 - 292
  • [26] Telomerase-specific replication-selective virotherapy for prostate cancer
    Kaku, Haruki
    Nasu, Yasutomo
    Huang, Peng
    Saika, Takashi
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    Kumon, Hiromi
    Urata, Yasuo
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (12): : 1454 - 1454
  • [27] The Use Of Replication-Selective Adenovirus In Detecting Circulating Tumor Cells In Lung
    Yang, X.
    Zhang, G.
    Liu, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [28] Safety of non-replicative and oncolytic replication-selective HSV vectors
    Epstein, Alberto L.
    Rabkin, Samuel D.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2024, 30 (08) : 781 - 794
  • [29] Replication-selective microbiological agents: fighting cancer with targeted germ warfare
    Kirn, DH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07): : 837 - 839
  • [30] ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
    Ries, S
    Korn, WM
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (01) : 5 - 11
12345